Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
Blue curve MMWR spacer

The content on this page is being archived for historic and reference purposes only. The content, links, and pdfs are no longer maintained and might be outdated.

Cancer Survivorship --- United States, 1971--2001

Because of advances in early detection and treatment, cancer has become a curable disease for some and a chronic illness for others. Underscoring this change, persons with diagnoses of cancer increasingly are described as "cancer survivors" rather than "cancer victims" (1,2). Cancer survivors include all living persons who ever received a diagnosis of cancer (1). To highlight how the population of cancer survivors has changed in the United States, the National Cancer Institute and CDC studied cancer data collected during 1971--2001. This report summarizes the results of that study, which determined that the number of persons living with cancer increased from 3.0 million (1.5% of the U.S. population) in 1971 to 9.8 million (3.5%) in 2001. A national health objective for 2010 is to increase to 70% the proportion of cancer patients who are living >5 years after diagnosis (objective no. 3-15), an objective already achieved for children with cancer but not yet for adults. The growing number of persons living with cancer poses challenges for researchers to understand the physical, psychosocial, and economic effects of surviving cancer and for public health practitioners to develop evidence-based programs to promote the health and well-being of cancer survivors.

This report uses incidence and follow-up data from registries in the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute to estimate the number of persons alive after a diagnosis of cancer and to monitor the progress in cancer survivorship (3). In addition, survival rates for persons receiving a diagnosis of cancer during 1991--2000 were compared with those receiving a cancer diagnosis during 1974--1976, the earliest dates for which SEER maintained data on survival; data collection for SEER began on January 1, 1973. To overcome the limited duration of data collection in all but the Connecticut registry (which began collecting data in 1935), estimates were adjusted to obtain lifetime or complete counts by using a statistical model that accounts for cases diagnosed before the start of the SEER program (4). The estimated number of cancer survivors was calculated by using data from SEER-9 registries to estimate the proportion of persons, by age, sex, and race, who were alive on January 1, 2001, and had a diagnosis of cancer during 1975--2000, taking into account loss to follow-up (4). These estimates were projected to U.S. population estimates, and data for all races combined were estimated by summing the counts for whites/unknown, blacks, and other races (5). Finally, the number of persons with a diagnosis of cancer no matter how long since the diagnosis was 1) estimated by adjusting the limited-duration data based on statistical modeling of incidence and survival, controlling for age and sex (6), and 2) validated by using 1940--1997 data from the historical Connecticut registry.

For all cancers combined, the number of survivors in the United States has increased steadily during the last three decades. In 1971, an estimated 3.0 million persons were living with cancer, representing approximately 1.5% of the population. In 2001, an estimated 9.8 million persons were cancer survivors, approximately 3.5% of the population (Figure 1). In the absence of other competing causes of death, an estimated 64% of adults whose cancer was diagnosed during 1995--2000 could expect to be alive 5 years after diagnosis, compared with 50% for those whose cancer was diagnosed during 1974--1976. Among children (i.e., persons aged <14 years), 79% of cancer survivors during 1991--2000 were expected to be alive at 5 years and approximately 75% at 10 years, compared with 56% expected to live >5 years after diagnosis during 1974--1976.

Among all cancer survivors in 2001, an estimated 14% had received a cancer diagnosis >20 years ago (Figure 2). More females than males were survivors, although more males than females received cancer diagnoses. In 2001, men had a higher proportion of lung cancer, for which survival chances are poor, whereas women had higher proportions of more readily detectable and treatable cancers (e.g., breast and gynecologic). Among cancer survivors in 2001, the most common primary cancer type was female breast cancer (22%), followed by prostate cancer (17%), colorectal cancer (11%), and gynecologic cancer (10%) (Figure 3). In 2001, an estimated 60% of all newly diagnosed cancers occurred among persons aged >65 years, who represented 61% of all cancer survivors. Thirty-three percent of cancer survivors were aged 40--64 years, 5% were aged 20--39 years, and <1% were aged <19 years.

Reported by: J Rowland, PhD, A Mariotto, PhD, N Aziz, MD, G Tesauro, MSW, EJ Feuer, PhD, Div of Cancer Control and Population Sciences, National Cancer Institute. D Blackman, PhD, P Thompson, Div of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion; LA Pollack, MD, EIS Officer, CDC.

Editorial Note:

Increases in the number of persons surviving for longer periods after a diagnosis of cancer have resulted from 1) earlier diagnoses through increased screening, 2) more effective treatment, 3) prevention of secondary disease and cancer recurrence, and 4) decreases in mortality from other causes. This increase has led to a broader definition for cancer survivors. Cancer also is associated with aging. As the U.S. population ages, increased effort will likely be needed to plan for the care and optimal health of older persons, many of whom will become cancer survivors.

The findings in this report are subject to at least four limitations. First, higher survival rates do not always result in lower cancer mortality rates (7); living longer with cancer might reflect how early the cancer was diagnosed rather than an improvement in outcome. Second, projection of race- and age-specific proportions from SEER to the U.S. population does not account for other prognostic factors (e.g., socioeconomic status and smoking). Third, persons with multiple tumors were categorized according to their first tumor; a person with melanoma and later breast cancer is counted as a survivor from melanoma but not from breast cancer. Estimators of the number of persons with cancer using different methods of counting multiple tumors are available (5). Finally, the estimates do not include broader health-status data that might indicate whether a survivor was cured, in active therapy, living with a chronic illness or disability, or dying from cancer. Methods that relate these factors to the trajectory of disease are being studied (8,9).

The findings raise critical issues for public health practitioners. A growing need exists to promote health, prevent secondary disease, and ensure the social, psychological, and economic well-being of long-term cancer survivors and their families. Public health initiatives typically have addressed the early detection and prevention of cancer, and the change in cancer survivorship in part reflects the success of these efforts. Acknowledging the growing numbers of cancer survivors, public health practitioners are expanding efforts to address cancer survivorship and transform research findings into practice. Public health organizations and their partners are developing programs to support survivors and their families across the continuum of cancer treatment, health promotion, and survival. Long-term surveillance that monitors the health and social well-being of survivors after 5 years could provide a knowledge base for cancer survivorship. Development of clinical guidelines could help health-care practitioners provide follow-up to survivors. Policymakers could be educated about economic concerns faced by survivors, such as employment and insurance discrimination.

The Office of Cancer Survivorship at the National Cancer Institute supports research that seeks to identify, examine, and prevent or control adverse long- and short-term effects associated with cancer. This office also disseminates information, such as the Facing Forward Series (available at, to enhance the quality of life of survivors. CDC is supporting states and tribal organizations in developing and incorporating survivorship priorities into their comprehensive cancer-control plans. Advocacy organizations (e.g., Lance Armstrong Foundation and National Coalition for Cancer Survivorship) promote education, awareness, and community programs that offer innovative after-treatment services and support for survivors. Recommendations from these and other organizations are included in the recently published National Action Plan for Cancer Survivorship: Advancing Public Health Strategies (available at (2), an Institute of Medicine report on Childhood Cancer Survivorship (10), and Living Beyond Cancer: Finding a New Balance from the President's Cancer Panel (available at Recommendations include establishing a representative registry of survivors, continuing research on the chronic and late effects of cancer, exploring programs that enable survivors to access and navigate complex health-care systems and coordinate care, creating clinical guidelines for follow-up care, developing public education programs on survivorship, and evaluating the effects and outcomes of these efforts.


  1. Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol 2003;13: 248--66.
  2. CDC, Lance Armstrong Foundation. A national action plan for cancer survivorship: advancing public health strategies. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 2004. Available at
  3. Surveillance, Epidemiology, and End Results (SEER) Program. SEERStat Database: incidence---SEER-9 regulations. Bethesda, Maryland: National Cancer Institute, Division of Cancer Control and Population Sciences, 2003. Available at
  4. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut Tumor Registry. N Engl J Med 1986;315:1394--7.
  5. Reis LA, Eisner MP, Kosary CL, et al., eds. SEER cancer statistics review, 1975--2000. Bethesda, Maryland: National Cancer Institute, 2003.
  6. Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol 2000;29: 197--207.
  7. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000;283:2975--8.
  8. Mariotto A, Warren JL, Knopf KB, Feuer EJ. The prevalence of colorectal cancer patients under care in the U.S. Cancer 2003;98: 1253--61.
  9. Phillips N, Coldman A, McBride ML. Estimating cancer prevalence using mixture models for cancer survival. Stat Med 2002;21:1257--70.
  10. Hewitt M, Weiner SL, Simone JV, eds., National Research Council. Childhood cancer survivorship: improving care and quality of life. Washington, DC: Institute of Medicine, 2003.

Figure 1

Figure 1
Return to top.

Figure 2

Figure 2
Return to top.

Figure 3

Figure 3
Return to top.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to

Page converted: 6/23/2004


Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A


Department of Health
and Human Services

This page last reviewed 6/23/2004